Brian Lian, Viking Therapeutics CEO

Viking CEO on ‘shock­ing’ mar­ket re­ac­tion to oral obe­si­ty da­ta, prepar­ing for Phase 3

SAN AN­TO­NIO — Promis­ing da­ta don’t al­ways equal a stock pop.

Viking Ther­a­peu­tics pre­sent­ed what an­a­lysts thought were com­pelling da­ta on an oral …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA